Gene · 538
Papers3,096
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,141 to 1,160 of 3,096
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The M1311V variant of ATP7A is associated with impaired trafficking and copper homeostasis in models of motor neuron disease. | Neurobiol Dis | 2021 | 33359139 | PubTator, text mining | PubMed |
| Suppression MGP inhibits tumor proliferation and reverses oxaliplatin resistance in colorectal cancer. | Biochem Pharmacol | 2021 | 33359068 | PubTator, text mining | PubMed |
| Function of the endolysosomal network in cholesterol homeostasis and metabolic-associated fatty liver disease (MAFLD). | Mol Metab | 2021 | 33348067 | PubTator, text mining | PubMed |
| MNK Inhibition Sensitizes KRAS-Mutant Colorectal Cancer to mTORC1 Inhibition by Reducing eIF4E Phosphorylation and c-MYC Expression. | Cancer Discov | 2021 | 33328217 | PubTator, text mining | PubMed |
| Regulation of murine copper homeostasis by members of the COMMD protein family. | Dis Model Mech | 2021 | 33262129 | PubTator, text mining | PubMed |
| Krebs von den Lungen 6 decreased in the serum and muscle of GNE myopathy patients. | Neuropathology | 2021 | 33225515 | PubTator, text mining | PubMed |
| Integration of transcriptomic, proteomic and metabolomic data to reveal the biological mechanisms of AAI injury in renal epithelial cells. | Toxicol In Vitro | 2021 | 33212167 | PubTator, text mining | PubMed |
| Biological applications of copper-containing materials. | Bioact Mater | 2021 | 33210018 | PubTator, text mining | PubMed |
| Insulin-promoted mobilization of GLUT4 from a perinuclear storage site requires RAB10. | Mol Biol Cell | 2021 | 33175605 | PubTator, text mining | PubMed |
| mTOR-targeted cancer therapy: great target but disappointing clinical outcomes, why? | Front Med | 2021 | 33165737 | PubTator, text mining | PubMed |
| Autophagy modulating agents as chemosensitizers for cisplatin therapy in cancer. | Invest New Drugs | 2021 | 33159673 | PubTator, text mining | PubMed |
| Galeterone sensitizes breast cancer to chemotherapy via targeting MNK/eIF4E and β-catenin. | Cancer Chemother Pharmacol | 2021 | 33159561 | PubTator, text mining | PubMed |
| Modulating phosphate consumption, a novel therapeutic approach for the control of cancer cell proliferation and tumorigenesis. | Biochem Pharmacol | 2021 | 33129806 | PubTator, text mining | PubMed |
| Cross-resistance of cisplatin selected cells to anti-microtubule agents: Role of general survival mechanisms. | Transl Oncol | 2021 | 33129114 | PubTator, text mining | PubMed |
| Copper metabolism as a unique vulnerability in cancer. | Biochim Biophys Acta Mol Cell Res | 2021 | 33091507 | PubTator, text mining | PubMed |
| Repurposing elesclomol, an investigational drug for the treatment of copper metabolism disorders. | Expert Opin Investig Drugs | 2021 | 33081534 | PubTator, text mining | PubMed |
| Cancer Plasticity: The Role of mRNA Translation. | Trends Cancer | 2021 | 33067172 | PubTator, text mining | PubMed |
| Temporal Proteomic Profiling of SH-SY5Y Differentiation with Retinoic Acid Using FAIMS and Real-Time Searching. | J Proteome Res | 2021 | 33054241 | PubTator, text mining | PubMed |
| Pharmacogenomics with red cells: a model to study protein variants of drug transporter genes. | Vox Sang | 2021 | 32996603 | PubTator, text mining | PubMed |
| Getting out what you put in: Copper in mitochondria and its impacts on human disease. | Biochim Biophys Acta Mol Cell Res | 2021 | 32979421 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/538/papers?page=58